Intraday mover · CRWV · Technology

CoreWeave (CRWV) active-mover surge cools on today’s intraday chart

Turnover stayed heavy as the GenAI cloud platform’s weekly rebound contrasted with weaker twelve-week and confirmation readings.

CoreWeave, Inc. Class A Common Stock
Latest90.67 USD
1W move26.3%
Volume1.0x
TrendInactive
Financial screen with CoreWeave stock data beside cloud-computing server infrastructure.

Market update

What happened

CoreWeave (CRWV) was prominent on the active-mover screen, with market data showing the shares at $107.73, up 19.3%. The today intraday price path showed the stock at $108.04 after easing 3.2% from a $111.61 start.

The latest weekly close was $90.67, leaving CoreWeave up 26.3% over one week and 2.0% over four weeks, but still down 15.5% over twelve weeks. The trend signal was inactive, Market Dynamics showed pressure at -0.97, and Relative Strength remained negative at -18.4.

Continue your research

Explore CRWV across Sharemaestro

These links are shown because current Sharemaestro data is available for this company.

Interactive chartReview weekly price, Trend Line, Fair Value, volume and Relative Strength.Full weekly reportOpen the full company report, financial profile and peer comparison.Technical analysisExamine support, resistance, momentum and the current trend readings.Trend historyReview how long the current trend has persisted and where it has changed.Sector comparisonCompare sector returns, breadth, leaders and weaker areas.Industry comparisonSee how this company’s industry is performing across its members.Company factorsCompare value, quality, growth, momentum and financial strength.News sentimentSee the balance, quality and freshness of recent company coverage.Buying and selling pressureReview longer-term accumulation, distribution and reversal readings.EarningsReview report dates, estimates, past results and earnings surprises.Options activitySee options positioning, expected move and unusual trading activity.Short interestReview short positioning, crowding and possible squeeze risk.

CRWV coverage

Evidence context